The stabilization of MORC2 is also related to breast cancer proliferation induced by estrogen and its analogs (such as 17β-estradiol) and resistance to antiestrogens (such as tamoxifen and fulvestrant) via a GPER1-PRKACA-CMA pathway [52]. Here, MORC2 is linked to breast carcinoma.